Tumor immune landscape could be divided into wound healing(C1), IFN-g dominant(C2), inflammatory(C3), lymphocyte depleted(C4), immunologically quiet(C5) and TGF-b dominant(C6) [27]. This evidence concerns the gene IFNG and neoplasm.